Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Skin cancer: T-VEC oncolytic viral therapy shows promise in melanoma.

Literature DB >> 26077044

Skin cancer: T-VEC oncolytic viral therapy shows promise in melanoma.

David Killock.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 26077044 DOI： 10.1038/nrclinonc.2015.106

Source DB: PubMed Journal: Nat Rev Clin Oncol ISSN： 1759-4774 Impact factor: 66.675

× No keyword cloud information.

1 in total

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

Authors: Robert H I Andtbacka; Howard L Kaufman; Frances Collichio; Thomas Amatruda; Neil Senzer; Jason Chesney; Keith A Delman; Lynn E Spitler; Igor Puzanov; Sanjiv S Agarwala; Mohammed Milhem; Lee Cranmer; Brendan Curti; Karl Lewis; Merrick Ross; Troy Guthrie; Gerald P Linette; Gregory A Daniels; Kevin Harrington; Mark R Middleton; Wilson H Miller; Jonathan S Zager; Yining Ye; Bin Yao; Ai Li; Susan Doleman; Ari VanderWalde; Jennifer Gansert; Robert S Coffin
Journal: J Clin Oncol Date: 2015-05-26 Impact factor: 44.544

1 in total

20 in total

1. Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.

Authors: Alena Cristina Jaime-Ramirez; Nina Dmitrieva; Ji Young Yoo; Yeshavanth Banasavadi-Siddegowda; Jianying Zhang; Theresa Relation; Chelsea Bolyard; Jeffrey Wojton; Balveen Kaur
Journal: J Gene Med Date: 2017-03 Impact factor: 4.565

Review 2. Trial Watch-Oncolytic viruses and cancer therapy.

Authors: Jonathan Pol; Aitziber Buqué; Fernando Aranda; Norma Bloy; Isabelle Cremer; Alexander Eggermont; Philippe Erbs; Jitka Fucikova; Jérôme Galon; Jean-Marc Limacher; Xavier Preville; Catherine Sautès-Fridman; Radek Spisek; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal: Oncoimmunology Date: 2015-12-08 Impact factor: 8.110

Skin cancer: T-VEC oncolytic viral therapy shows promise in melanoma.

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.

1. Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.

Review 2. Trial Watch-Oncolytic viruses and cancer therapy.

3. First oncolytic virus approved for melanoma immunotherapy.

4. Combination of Plant Virus Nanoparticle-Based in Situ Vaccination with Chemotherapy Potentiates Antitumor Response.

Review 5. The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer

Review 6. Imaging-based Biomarkers for Predicting and Evaluating Cancer Immunotherapy Response.

7. In Vivo Live Imaging of Oncolytic Mammalian Orthoreovirus Expressing NanoLuc Luciferase in Tumor Xenograft Mice.

8. Complex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses.

Review 9. Oncolytic virotherapy using herpes simplex virus: how far have we come?

Review 10. Immunotherapy for Pediatric Brain Tumors.